15 February 2021 Priya Vaidya 3009 Case Updates Neurim Pharmaceuticals v Generics UK Limited [2020] EWHC 3270 (Pat) by Priya Vaidya The case: A patent case relating to prolonged release pharmaceutical formulations in which the active ingredient melatonin is intended to improve the restorative quality of sleep in a patient suffering from primary insomnia characterised by non-restorative sleep. The case called for experts in sleep medicine. To continue reading you must be an EWI member, become a member and access exclusive content. Already a member? Login Share Print Tags Bias06. Rules and Regulations11. Report Writing Related articles A Day in the Life of an Occupational Therapy Expert Witness Expert Report or MG11 form? Lorimer-Wing v Hashmi [2026] EWHC 1843 (Ch) Dermot Speight & Ors (as trustees of the Thornaby Angling Association) v Robert James Pickersgill [2026] EWCC 48 Be cautious when accepting instructions from a Litigant in Person Switch article R (IJ (Kosovo)) v Secretary of State for the Home Department [2020] EWHC 3487 (Admin) Previous Article B v A [2020] EWHC 3138 (Fam) Next Article Comments are only visible to subscribers.